ITI Pharma & Healthcare Fund - Regular Plan - Growth

NAV 14.84(-0.51%)
Mar 13, 2025
ITI Pharma & Healthcare Fund - Regular Plan - Growth
AUM
₹200 Cr
Expense (%)
2.35
Turnover (%)
0.62
Benchmark
Nifty Healthcare Index - TRI
Asset Quality
Large, Green
Differs from benchmark (%)
94.67

Decision Maker

1. Right Fund

Performance
Quality

2. Right Time

Benchmark
Debt Fund
8%
Likely Future 5 Year CAGR.

3. Right Allocation

Will this Fund help diversify your portfolio?

3Yr Rolling Returns(%)

Benchmark# : NIFTY 500

Performance Summary - 10 Year X-Ray

Dec' 15Dec' 16Dec' 17Dec' 18Dec' 19Dec' 20Dec' 21Dec' 22Dec' 23Dec' 24YTD
NAV(₹)
------10.279.3712.3417.4314.84
AUM(Cr.)
------179.31152.30143.28230.79200.83
Benchmark# BM# Returns(%)
------2.383.0225.7715.16-9.83
Fund Returns(%)
------4.05-8.7631.7041.25-14.86
Implied  Investor Returns(%) IR(%)
------122.58-11.9826.6246.29-64.94
Alpha(%)  (Returns over Benchmark)
------1.67-11.785.9326.09-5.03
Expense Ratio(%)
------2.542.372.342.352.35

CAGR

9 Year5 Year3 Year1 Year
Benchmark# BM# Returns(%)
--11.59-0.7
Fund Returns(%)
--16.87.68
Implied  Investor Returns(%) IR
--12.725.25
                                                                                                                                                            Benchmark# is NIFTY 500

ITI Pharma & Healthcare Fund Review : 14 Mar 2025

ITI Pharma & Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care with an 201(Cr) AUM. It is Open Ended scheme launched on 08 Nov 2021. Currently, Rohan Korde and Dhimant Shah as the fund managers managing the fund. Benchmark of the scheme is Nifty Healthcare Index - TRI.

1. How has the ITI Pharma & Healthcare Fund Performed in the past? N/A

  • The fund has been operational for less than 5 years and hence it too early to be rated on Performance consistency.
  • The 3, 5 and 9-year average rolling returns and rolling alpha are not available
  • For last 5 years, Investors have earned close to or more returns than the Fund. This may indicate that they were aligned to the investing process followed by the fund.

2. How is the Quality of ITI Pharma & Healthcare Fund? Q

Fund's Portfolio Quality is Somewhat Good. It has a large proportion of Green and Orange Stocks.
  • Portfolio Composition

    The fund is 98% in equity and hold 39 number of stocks. The Top 3 stocks are Suven Pharma, Lupin and Sun Pharma Inds. and account for 28% of its portfolio. Top 5 and 10 stocks of fund account for 39% and 58% of fund’s portfolio respectively. Top three sectors of funds are Healthcare, Miscellaneous and Chemicals accounting for 99% of the total portfolio.
  • 3. Should you SIP in ITI Pharma & Healthcare Fund? N/A Q

    • It is better to invest in a fund with a longer track record as this fund cannot be assessed for consistency of out-performance.
    • Fund's returns are more likely to be different than its benchmark NIFTY 500 returns, as Fund’s portfolio is significantly different.
    • You need to look at the other funds in your portfolio and ensure this fund helps diversify your portfolio meaningfully.
    • Before investing a large lumpsum amount in a fund you need to assess its Upside Potential. You can contact us for advice.

    4. What are the Risks in the ITI Pharma & Healthcare Fund?

    • ITI Pharma & Healthcare Fund is likely to fall lesser than the market. It is likely to do well in a falling market but not in a rising market.
    • The Fund has fallen harder, but not recovered faster than its Benchmark.

    Underlying Asset Quality & Valuation

    Underlying Asset Quality Valuation(%)
    Underlying Asset Valuation (%)

    Peer Comparison on returns

    Upside and Downside Capture Ratio

    1 Year3 Year5 Year9 Year
    Upside %
    122104--
    Downside %
    30342832

    Statistical Measure*

    Mean Std Dev Sharpe Sortino Beta Alpha
    Fund
    0.00%0.88-0.01-0.020.59-5.03%
    Benchmark#
    0.05%0.970.030.050.59-
    *Based on daily returns for past 1 year.

    Mean and Standard Deviation

    Average Rolling Return Standard Deviation
    1 Year 3 Year5 Year9 Year1 Year3 Year5 Year9 Year
    Fund
    28.0717.030.000.0022.282.740.000.00
    Benchmark#
    21.9012.700.000.0015.432.100.000.00
    Drawdown and Recovery Period

    No Data Found

    Top 10 Holdings

    Company (Q)Sector% Assets
    Healthcare15.86
    Healthcare6.26
    Healthcare6.06
    Healthcare5.67
    Healthcare5.02
    Healthcare4.65
    Healthcare4.23
    Healthcare4
    Healthcare3.35
    Healthcare2.95

    Fund Overview ITI Pharma & Healthcare Fund - Regular Plan - Growth

    Launch Date
    08 Nov 2021
    Benchmark
    Nifty Healthcare Index - TRI
    Performance comparison Benchmark#
    NIFTY 500
    Riskometer
    Very High
    Turnover
    0.62%
    Type
    Open ended scheme
    Return Since Launch
    12.49%
    Min. Investment
    5000.00
    Min. Additional investment Min. Add. inv.
    1000.00
    Min. SIP
    500.00
    Min. Cheques
    12
    Min. Withdrawal
    1000.00
    Exit Load
    1.00%
    Remark
    1% on or before 12M, Nil after 12M
    PortfolioCompare

    FAQ : ITI Pharma & Healthcare Fund - Regular Plan - Growth

    ITI Pharma & Healthcare Fund - Regular Plan - Growth has delivered CAGR and average rolling returns as follows :

    1 Year 3 Year 5 Year 9 Year
    CAGR(%) 7.68 16.8 N/A N/A
    Average Rolling Returns(%) 28.07 17.03 N/A N/A

    The Current NAV of ITI Pharma & Healthcare Fund - Regular Plan - Growth is ₹14.84.

    It is better to invest in a fund with a longer track record as ITI Pharma & Healthcare Fund - Regular Plan - Growth cannot be assessed for consistency of out-performance. Funds returns are more likely to be different than its benchmark NIFTY 500 returns, as Funds portfolio is significantly different.

    ITI Pharma & Healthcare Fund - Regular Plan - Growth fund’s expense ratio is 2.35%

    The process for redemption is

    • Give a request for redemption of the number of units or the amount you want. The request will be acknowledged.
    • You will get information about the redemption and the NAV at which redeemed.
    • The amount will be deposited in the designated bank account.

    The AUM of ITI Pharma & Healthcare Fund - Regular Plan - Growth is currently ₹201 Crores.

    The Top three stocks are Sun Pharma Inds., Lupin and Suven Pharma and account for 28% of its portfolio. Top 5 and 10 stocks of fund account for 39% and 58% of fund’s portfolio respectively.

    Top three sectors of ITI Pharma & Healthcare Fund - Regular Plan - Growth fund are Healthcare, Miscellaneous and Chemicals accounting for 99% of the total portfolio.

    Funds Portfolio Quality is Somewhat Good. It has a large proportion of Green and Orange Stocks.Since this is a Equity - Sectoral Fund - Pharma & Health Care it is comparatively safer to invest in this fund. However, since it has not consistently outperformed its benchmark index on an average 3-year rolling returns basis it is not the most suitable fund for SIP.

    The category of ITI Pharma & Healthcare Fund - Regular Plan - Growth Fund is Equity - Sectoral Fund - Pharma & Health Care.

    Rohan Korde and Dhimant Shah manage the ITI Pharma & Healthcare Fund - Regular Plan - Growth Fund.

    ITI Pharma & Healthcare Fund - Regular Plan - Growth current PE ratio is 48.97 and PB ratio is 7.13

    The asset allocation of ITI Pharma & Healthcare Fund - Regular Plan - Growth is Stocks : 97.88%, Debt : 2.15% and Gold : 0%

    The minimum SIP amount for ITI Pharma & Healthcare Fund - Regular Plan - Growth is ₹500.00 and minimum lumpsum is ₹5000.00

    The exit load for ITI Pharma & Healthcare Fund - Regular Plan - Growth is 1% on or before 12 months, Nil after 12 months

    © 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
    Please wait your portfolio is updating...